International Stem Cell CORP SEC filings ISCO

International Stem Cell CORP has 825 filings in SEC EDGAR's recent list, going back to Apr 4, 2006. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 8, 2026 (acquisition or sale of assets). The company's fiscal year ends on December 31.

International Stem Cell CORP SEC filings
Form Description Filed Period
8-K Current report
Acquisition or sale of assets
Sep 8, 2026 Sep 1, 2026
10-Q Quarterly report Aug 13, 2026 Jun 30, 2026
DEF 14C Information statement Aug 4, 2026 Aug 4, 2026
PRE 14C Preliminary information statement Jul 24, 2026 Jul 24, 2026
8-K Current report
Material agreement
Jul 16, 2026 Jul 10, 2026
8-K Current report
Shareholder vote results
Jun 12, 2026 Jun 11, 2026
10-Q Quarterly report May 14, 2026 Mar 31, 2026
ARS Annual report to shareholders Apr 29, 2026 Dec 31, 2025
DEF 14A Proxy statement Apr 29, 2026 Jun 11, 2026
10-K Annual report Mar 30, 2026 Dec 31, 2025
8-K Current report
Shareholder vote results
Nov 18, 2025 Jun 17, 2025
10-Q Quarterly report Nov 13, 2025 Sep 30, 2025
8-K Current report
Material agreement, New debt
Sep 16, 2025 Sep 15, 2025
10-Q Quarterly report Aug 14, 2025 Jun 30, 2025
10-Q Quarterly report May 14, 2025 Mar 31, 2025
ARS Annual report to shareholders Apr 24, 2025 Dec 31, 2024
DEF 14A Proxy statement Apr 24, 2025 Jun 17, 2025
10-K Annual report Mar 28, 2025 Dec 31, 2024
10-Q Quarterly report Nov 13, 2024 Sep 30, 2024
8-K Current report
Material agreement, New debt
Sep 17, 2024 Sep 15, 2024
10-Q Quarterly report Aug 13, 2024 Jun 30, 2024
10-Q Quarterly report May 14, 2024 Mar 31, 2024
ARS Annual report to shareholders Apr 26, 2024 Dec 31, 2023
DEF 14A Proxy statement Apr 25, 2024 Jun 11, 2024
S-8 Employee stock plan registration Mar 28, 2024 —
10-K Annual report Mar 28, 2024 Dec 31, 2023
10-Q Quarterly report Nov 13, 2023 Sep 30, 2023
DEF 14C Information statement Sep 27, 2023 Sep 27, 2023
8-K Current report
Material agreement, New debt
Sep 18, 2023 Sep 15, 2023
10-Q Quarterly report Aug 11, 2023 Jun 30, 2023
8-K Current report
Shareholder vote results
Jun 21, 2023 Jun 14, 2023
10-Q Quarterly report May 12, 2023 Mar 31, 2023
ARS Annual report to shareholders Apr 28, 2023 Dec 31, 2022
DEF 14A Proxy statement Apr 28, 2023 Jun 14, 2023
10-K Annual report Mar 30, 2023 Dec 31, 2022
8-K Current report
Material agreement, New debt
Mar 16, 2023 Mar 15, 2023
10-Q Quarterly report Nov 14, 2022 Sep 30, 2022
8-K Current report
Material agreement, New debt
Sep 16, 2022 Sep 15, 2022
10-Q Quarterly report Aug 12, 2022 Jun 30, 2022
8-K Current report
Shareholder vote results
Jun 14, 2022 Jun 9, 2022
10-Q Quarterly report May 13, 2022 Mar 31, 2022
8-K Current report
Officer or director change
Apr 29, 2022 Apr 25, 2022
DEF 14A Proxy statement Apr 27, 2022 Jun 9, 2022
10-K Annual report Mar 29, 2022 Dec 31, 2021
8-K Current report
Material agreement, New debt
Mar 3, 2022 Mar 1, 2022
8-K Current report
Officer or director change
Feb 2, 2022 Feb 1, 2022
8-K Current report
Material agreement, New debt
Jan 14, 2022 Jan 13, 2022
8-K Current report
Agreement ended
Dec 28, 2021 Dec 27, 2021
10-Q Quarterly report Nov 12, 2021 Sep 30, 2021
8-K Current report
Material agreement
Nov 1, 2021 Oct 26, 2021
10-Q Quarterly report Aug 13, 2021 Jun 30, 2021
8-K Current report
Bylaw or fiscal year change
Jun 30, 2021 Jun 25, 2021
8-K Current report
Shareholder vote results
Jun 14, 2021 Jun 9, 2021
10-Q Quarterly report May 14, 2021 Mar 31, 2021
DEF 14A Proxy statement Apr 29, 2021 Jun 9, 2021
10-K Annual report Mar 30, 2021 Dec 31, 2020
8-K Current report
Material agreement, New debt
Mar 8, 2021 Mar 5, 2021
8-K Current report
Material agreement, New debt
Jan 19, 2021 Jan 15, 2021
10-Q Quarterly report Nov 12, 2020 Sep 30, 2020
10-Q Quarterly report Aug 12, 2020 Jun 30, 2020
8-K Current report
Shareholder vote results
Jun 29, 2020 Jun 23, 2020
10-Q Quarterly report Jun 19, 2020 Mar 31, 2020
DEF 14A Proxy statement Jun 2, 2020 Jun 23, 2020
10-K Annual report Jun 1, 2020 Dec 31, 2019
8-K Current report
Other events
May 13, 2020 May 13, 2020
NT 10-K Filing May 13, 2020 Dec 31, 2019
8-K Current report
Other events
Apr 28, 2020 Apr 28, 2020
8-K Current report
Other events
Mar 30, 2020 Mar 30, 2020
8-K Current report
Material agreement, New debt
Dec 19, 2019 Dec 17, 2019
10-Q Quarterly report Nov 12, 2019 Sep 30, 2019
10-Q Quarterly report Aug 27, 2019 Jun 30, 2019
NT 10-Q Filing Aug 14, 2019 Jun 30, 2019
8-K Current report
Auditor change
Jul 30, 2019 Jul 25, 2019
8-K Current report
Shareholder vote results
Jun 7, 2019 Jun 3, 2019
10-Q Quarterly report May 15, 2019 Mar 31, 2019
DEF 14A Proxy statement Apr 30, 2019 Jun 3, 2019
8-K Current report
Material agreement
Apr 23, 2019 Apr 17, 2019
10-K Annual report Apr 15, 2019 Dec 31, 2018
NT 10-K Filing Apr 1, 2019 Dec 31, 2018
8-K Current report
Material agreement, Unregistered share sale
Jan 23, 2019 Jan 21, 2019
8-K Current report
Material agreement
Nov 15, 2018 Nov 12, 2018
10-Q Quarterly report Nov 14, 2018 Sep 30, 2018
8-K Current report
Unregistered share sale
Oct 3, 2018 Sep 27, 2018
S-8 Employee stock plan registration Aug 15, 2018 —
10-Q Quarterly report Aug 14, 2018 Jun 30, 2018
8-K Current report
Shareholder vote results
Jun 27, 2018 Jun 21, 2018
8-K Current report
Material agreement
Jun 5, 2018 May 31, 2018
10-Q Quarterly report May 21, 2018 Mar 31, 2018
8-K Current report
Material agreement
May 16, 2018 May 14, 2018
NT 10-Q Filing May 15, 2018 Mar 31, 2018
DEF 14A Proxy statement Apr 30, 2018 Jun 21, 2018
10-K Annual report Apr 9, 2018 Dec 31, 2017
NT 10-K Filing Apr 2, 2018 Dec 31, 2017
8-K Current report
Material agreement
Mar 8, 2018 Mar 6, 2018
RW Filing Mar 8, 2018 —
8-K Current report
Officer or director change
Feb 21, 2018 Feb 13, 2018
8-K Current report
Material agreement, Unregistered share sale
Dec 13, 2017 Dec 7, 2017
10-Q Quarterly report Nov 14, 2017 Sep 30, 2017
8-K Current report
Material agreement
Sep 6, 2017 Sep 1, 2017
8-K Current report
Officer or director change
Aug 25, 2017 Aug 22, 2017
10-Q Quarterly report Aug 11, 2017 Jun 30, 2017
EFFECT Filing Jun 14, 2017 —
POS AM Form posam Jun 9, 2017 —
8-K Current report
Material agreement
Jun 8, 2017 Jun 2, 2017
8-K Current report
Shareholder vote results
Jun 6, 2017 May 31, 2017
10-Q Quarterly report May 15, 2017 Mar 31, 2017
DEF 14A Proxy statement Apr 28, 2017 May 31, 2017
10-K Annual report Mar 31, 2017 Dec 31, 2016
8-K Current report
Material agreement
Mar 22, 2017 Mar 20, 2017
8-K Current report
Material agreement
Feb 28, 2017 Feb 22, 2017
8-K Current report
Material agreement
Jan 18, 2017 Jan 12, 2017
8-K Current report
Unregistered share sale
Dec 13, 2016 Dec 8, 2016
10-Q Quarterly report Nov 14, 2016 Sep 30, 2016
8-K Current report
Unregistered share sale
Sep 19, 2016 Sep 14, 2016
8-K Current report
Unregistered share sale
Aug 24, 2016 Aug 22, 2016
10-Q Quarterly report Aug 15, 2016 Jun 30, 2016
8-K Current report
Unregistered share sale
Jul 6, 2016 Jun 29, 2016
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
May 19, 2016 May 13, 2016
S-8 Employee stock plan registration May 17, 2016 —
10-Q Quarterly report May 16, 2016 Mar 31, 2016
424B4 Prospectus May 10, 2016 —
EFFECT Filing May 9, 2016 —
S-1 Registration statement Apr 20, 2016 —
DEF 14A Proxy statement Apr 18, 2016 May 13, 2016
PRE 14A Preliminary proxy statement Apr 7, 2016 May 13, 2016
10-K Annual report Mar 30, 2016 Dec 31, 2015
8-K Current report
Material agreement, New debt
Mar 10, 2016 Mar 9, 2016
8-K Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change, Other events
Mar 10, 2016 Mar 9, 2016
8-K Current report
Material agreement
Mar 3, 2016 Mar 3, 2016
8-K Current report
Material agreement, Unregistered share sale
Jan 12, 2016 Jan 8, 2016
8-K Current report
Material agreement, New debt
Dec 15, 2015 Dec 10, 2015
S-1/A Amended registration statement Dec 14, 2015 —
8-K Current report
Other events
Dec 14, 2015 Dec 14, 2015
8-K Current report
Bylaw or fiscal year change
Dec 4, 2015 Dec 3, 2015
8-K Current report
Unregistered share sale
Nov 30, 2015 Nov 23, 2015
S-1/A Amended registration statement Nov 25, 2015 —
10-Q Quarterly report Nov 13, 2015 Sep 30, 2015
8-K Current report
Material agreement, New debt
Nov 4, 2015 Nov 3, 2015
EFFECT Filing Nov 2, 2015 —
POS AM Filing Oct 23, 2015 —
8-K Current report
Material agreement, New debt
Oct 14, 2015 Oct 9, 2015
424B3 Prospectus Oct 13, 2015 —
8-K Current report
Material agreement
Oct 13, 2015 Oct 10, 2015
S-8 Employee stock plan registration Sep 14, 2015 —
8-K Current report
Officer or director change
Sep 14, 2015 Sep 11, 2015
8-K Current report
Material agreement, New debt
Sep 9, 2015 Sep 9, 2015
8-K Current report
Material agreement, New debt
Aug 13, 2015 Aug 10, 2015
10-Q Quarterly report Aug 13, 2015 Jun 30, 2015
8-K Current report
Unregistered share sale
Aug 11, 2015 Aug 5, 2015
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
Jul 28, 2015 Jul 22, 2015
S-1 Registration statement Jun 24, 2015 —
8-K Current report
Officer or director change
Jun 5, 2015 Jun 3, 2015
8-K Current report
Material agreement, New debt
May 14, 2015 May 12, 2015
10-Q Quarterly report May 11, 2015 Mar 31, 2015
8-K Current report
Shareholder vote results
May 11, 2015 May 7, 2015
8-K Current report
Material agreement, New debt
May 8, 2015 May 6, 2015
8-K Current report
Officer or director change
Apr 30, 2015 Apr 27, 2015
8-K Current report
Unregistered share sale
Apr 23, 2015 Apr 22, 2015
424B3 Prospectus Apr 15, 2015 —
424B3 Prospectus Apr 15, 2015 —
8-K Current report
Material agreement
Apr 15, 2015 Apr 14, 2015
8-K Current report
Results of operations
Apr 1, 2015 Mar 31, 2015
DEF 14A Proxy statement Mar 31, 2015 May 7, 2015
10-K Annual report Mar 30, 2015 Dec 31, 2014
8-K Current report
Unregistered share sale
Mar 23, 2015 Mar 18, 2015
EFFECT Filing Feb 6, 2015 —
424B3 Prospectus Feb 6, 2015 —
S-1 Registration statement Jan 16, 2015 —
8-K Current report
Other events
Jan 7, 2015 Dec 31, 2014
8-K Current report
Unregistered share sale
Dec 29, 2014 Dec 22, 2014
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Dec 5, 2014 Dec 4, 2014
EFFECT Filing Nov 25, 2014 —
424B4 Prospectus Nov 25, 2014 —
S-1/A Amended registration statement Nov 21, 2014 —
8-K Current report
Material agreement
Nov 18, 2014 Nov 13, 2014
10-Q Quarterly report Nov 13, 2014 Sep 30, 2014
8-K Current report
Results of operations
Nov 13, 2014 Nov 13, 2014
DEFA14A Additional proxy material Nov 3, 2014 —
S-1 Registration statement Nov 3, 2014 —
DEF 14A Proxy statement Oct 29, 2014 Dec 4, 2014
UPLOAD Letter from the SEC Oct 24, 2014 —
D Filing Oct 23, 2014 —
CORRESP Letter to the SEC Oct 23, 2014 —
UPLOAD Letter from the SEC Oct 22, 2014 —
PRE 14A Preliminary proxy statement Oct 17, 2014 Dec 4, 2014
8-K Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change, Other events
Oct 8, 2014 Oct 7, 2014
8-K Current report
Material agreement
Sep 16, 2014 Sep 10, 2014
8-K Current report
Results of operations
Aug 12, 2014 Aug 12, 2014
8-K Current report
Material agreement
Aug 11, 2014 Aug 6, 2014
10-Q Quarterly report Aug 8, 2014 Jun 30, 2014
8-K Current report
Material agreement
Jul 1, 2014 Jun 26, 2014
8-K Current report
Material agreement, Unregistered share sale
Jun 12, 2014 Jun 11, 2014
8-K Current report
Material agreement
Jun 4, 2014 May 29, 2014
424B3 Prospectus May 22, 2014 —
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
May 14, 2014 May 8, 2014
8-K Current report
Results of operations
May 13, 2014 May 13, 2014
10-Q Quarterly report May 13, 2014 Mar 31, 2014
EFFECT Filing Apr 10, 2014 —
424B3 Prospectus Apr 10, 2014 —
POS AM Filing Apr 2, 2014 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
ISCO (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
San Diego, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1355790
Former names
BTHC III INC. (until Jan 19, 2007)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.